Obesity White Papers & Case Studies

  1. The Case For A New Paradigm In Geographic Atrophy Clinical Trials 10/15/2025

    Here, the author introduces a new framework for GA clinical development that integrates genetic profiling, novel biomarkers, and predictive analytics to improve precision, streamline design, and accelerate development.

  2. Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success 10/15/2025

    The CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.

  3. Real-World Data And Real-World Evidence 10/15/2025

    As clinical research evolves, RWD and RWE play a crucial role in complementing conventional randomized controlled trials (RCTs) by capturing insights that accurately reflect clinical practice.

  4. Starting A New Study? This One's For You 10/15/2025

    Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.

  5. High Potency Handling Capabilities And Support 10/15/2025

    Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.

  6. Formulation Development Services 10/15/2025

    Quickly address critical formulation issues and optimizing performance. Explore services for small molecules and synthetic peptides across oral, topical, rectal, and parenteral routes.

  7. Accelerating FIH Trials To POC With Speed, Safety, And Certainty 10/15/2025

    Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.

  8. Conducting Early Phase Clinical Trials In Diverse Healthy Populations 10/14/2025

    Download our guide to learn proven strategies for designing early phase clinical trials that successfully enroll diverse populations and meet FDA diversity guidance.

  9. Global Vaccine Clinical Trials: Australia's Strategic Advantage 10/14/2025

    The global vaccine clinical trials landscape presents unprecedented opportunities. This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine development.

  10. Eliminate Clinical Trial White Space With The Right AI Strategy 10/9/2025

    Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.